Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

MannKind (MNKD -23.7%) takes a hit after pricing its MNKD <font...

  • Thursday, October 18, 2012, 11:26 AM ET
    MannKind (MNKD -23.7%) takes a hit after pricing its MNKD <font color="red">-23.7%</font>) takes a hit after pricing 40M shares of stock and warrants for another aggregate 30M. Each share of common is being sold together with a warrant for 0.75 shares of common at $2.00. The drug developer is looking to raise funds for general corporate purposes. The company had 199.4 million shares outstanding as of August.">secondary offering of 40M shares of stock and warrants for another aggregate 30M. Each share of common is being sold together with a warrant for 0.75 shares of common at $2.00. The drug developer is looking to raise funds for general corporate purposes. The company had 199.4 million shares outstanding as of August.
Track new comments on this story

This news story has 1 comment:

  •  
    INCREDIBLE!!!! AL and the boys just keep beating this to death and have no regard for anyone ( small investors ) other than themselves. Why not just give the shares away? pretty close to the same thing if you look at the shares outstanding and the dillution. Pretty crappy in my opinion! We paid top dollar for the common and now the newbies get a freebee along with the purchase. Thank you Al for rewarding us that have been so patient!!!!
    18 Oct 2012, 01:40 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »